Marker Therapeutics (MRKR) Misses Q3 EPS by 26c
Tweet
Share
E-mailGet Alerts MRKR Hot Sheet
Join SI Premium – FREE
Marker Therapeutics (NASDAQ: MRKR) reported Q3 EPS of ($0.26). Revenue for the quarter came in at $1.93 million.
For earnings history and earnings-related data on Marker Therapeutics (MRKR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- Uranium Royalty Corp. sets shareholder vote on $1.14B Sweetwater deal
- JPMorgan Downgrades Astral Ltd (ASTRA:IN) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
